Dr. Danelis Priscilla Ayala-Carrasquillo , MD
General Practice β’ Ocala, FL
2202 Se 17th St
Ocala, FL 344712623
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Danelis Ayala-Carrasquillo is listed in NPPES under General Practice.
-
NPI assigned on January 27, 2022; this date does not establish years in practice.
-
Published CMS data list 4,084 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium β 279 prescription fills, including refills.
- Alprazolam β 146 prescription fills, including refills.
- Gabapentin β 141 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 101 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Ocala, FL (2024, 36 clinicians with data). Median for this group: 4,408. Middle half: 1,275 to 6,244.
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 195 in 2023 to 4,084 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2023β2024.
Practice Location & Contact Primary Location
2202 Se 17th St
Ocala, FL 344712623
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
8,434 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$404,570 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,015.43 across 66 records.
By nature of payment
- Food and Beverage: $1,015.43 across 66 records.
Reporting-company totals (3 largest of 17)
- Bayer Healthcare Pharmaceuticals Inc.: $278.78 across 28 records.
- AstraZeneca Pharmaceuticals LP: $156.41 across 7 records.
- Eli Lilly and Company: $123.23 across 6 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ayala-Carrasquillo has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ayala-Carrasquillo as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ocala and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Ocala, FL (2024, 36 clinicians with data). Median for this group: 4,408. Middle half: 1,275 to 6,244.
Close to the middle for clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under General Practice in Ocala, FL (2024, 36 clinicians with data). Median for this group: $232,243. Middle half: $28,108 to $417,554.
A higher Part D drug cost than 70% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: $166,180. Middle half: $16,824 to $452,832.
50 active clinicians are listed under General Practice with a practice address in Ocala, FL (2,293 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Ocala
20% of these 50 clinicians have the CMS telehealth indicator.
62% of these 50 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1994% from 195 in 2023 to 4,084 in 2024.
- 2023: 195
- 2024: 4,084
-
30-day fills
30-day fills increased 2897% from 281 in 2023 to 8,434 in 2024.
- 2023: 281
- 2024: 8,434
-
Part D drug cost
Part D drug cost increased 20813% from $1,935 in 2023 to $404,570 in 2024.
- 2023: $1,935
- 2024: $404,570
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $99.60 in 2022 to $1,015.43 in 2025.
- 2022: $99.60
- 2023: $369.41
- 2024: $868.52
- 2025: $1,015.43
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 66 records totaling $1,015.43.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $37.72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $30.44 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $26.85 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $26.05 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
β | General | $24.36 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $24.18 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $24.11 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $23.65 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $23.31 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $23.18 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $23.18 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $22.96 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $22.96 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
β | General | $22.81 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $21.74 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $21.38 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $21.04 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $20.92 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $20.43 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $20.41 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
β | General | $19.94 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
β | General | $19.30 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $18.78 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $18.59 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 279 | 24,217 | $2,655.25 | 157 |
| Alprazolam | Alprazolam | 146 | 4,417 | $435.05 | 36 |
| Gabapentin | Gabapentin | 141 | 10,188 | $2,229.91 | 79 |
| Levothyroxine Sodium | Levothyroxine Sodium | 140 | 11,790 | $1,806.36 | 77 |
| Losartan Potassium | Losartan Potassium | 134 | 10,929 | $1,234.86 | 72 |
| Lisinopril | Lisinopril | 117 | 9,900 | $431.58 | 60 |
| Metformin Hcl | Metformin Hcl | 101 | 8,005 | $487.25 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 2,561 | $1,884.20 | 51 |
| Clonazepam | Clonazepam | 94 | 3,074 | $1,056.24 | 27 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 82 | 450 | $234.22 | 70 |
| Omeprazole | Omeprazole | 75 | 5,370 | $1,194.16 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 75 | 3,000 | $381.18 | 24 |
| Fenofibrate | Fenofibrate | 71 | 5,869 | $1,749.27 | 44 |
| Amlodipine Besylate | Amlodipine Besylate | 68 | 5,688 | $492.08 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 65 | 5,760 | $646.92 | 36 |
| Meloxicam | Meloxicam | 62 | 2,387 | $127.53 | 33 |
| Azithromycin | Azithromycin | 61 | 297 | $375.08 | 52 |
| Ozempic | Semaglutide | 61 | 2,878 | $70,971.87 | 26 |
| Trazodone Hcl | Trazodone Hcl | 60 | 4,080 | $423.22 | 28 |
| Prednisone | Prednisone | 58 | 941 | $152.85 | 44 |
| Celecoxib | Celecoxib | 57 | 2,253 | $3,828.48 | 34 |
| Pregabalin | Pregabalin | 55 | 2,562 | $2,678.69 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 54 | 4,566 | $273.22 | 30 |
| Farxiga | Dapagliflozin Propanediol | 54 | 3,900 | $71,295.40 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 50 | 4,150 | $290.33 | 28 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-12-14NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20240212004303
FL
0749623247
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
General Practice
Doctor of Medicine (M.D.)
General Practice
Doctor of Medicine (M.D.)
General Practice
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2202 SE 17TH ST, OCALA, FL 344712623 (Tel: 3525799555)
Registered at 120 HICKORY COURSE LOOP, OCALA, FL 344724399 (Tel: 7872250890)
General Practice (license number reported to NPPES: PR 23142)
Registered at 6020 BIRCHILL RD, WATAUGA, TX 761481663 (Tel: 7872250890)
Recorded as DANELIS AYALA-CARRASQUILLO, MD
NPI status registered as active in NPPES database
Registered at 70 CALLE SANTA CRUZ, BAYAMON, PR 009617052 (Tel: 7876204747)
Registered at PO BOX 236, BAYAMON, PR 009600236 (Tel: 7876204747)
Recorded as DANELIS AYALA, MD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Ocala
- Dr. Lynnette Santana, MD
- Dr. Jose Torres-Rodriguez, MD
- Jackeline Lopez Ruiz
- Dr. Alfonso Martinez, MD
- Dr. Christian Lopez, MD
- Dr. Lindsey Ferko, DO
Mailing Address
120 Hickory Course Loop
Ocala, FL 344724399
Phone: 7872250890